However, since tumor-infiltrating CD8+ T and Tregs express PD-1 at equivalent high level, blocking this signaling pathway will not only activate CD8+ Teffs, but also enhance the immunosuppressive activity of Tregs (22). Here, CD8A is linked to neoplasm.